These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3755301)

  • 1. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins.
    Selvidge LA; Eftink MR
    Anal Biochem; 1986 May; 154(2):400-8. PubMed ID: 3755301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorimetric determination of beta-cyclodextrin: two assay modifications based on molecular complexation of phenolphtalein.
    Mäkelä M; Korpela T; Laakso S
    J Biochem Biophys Methods; 1987 Apr; 14(2):85-92. PubMed ID: 3693795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic study of beta-cyclodextrin-dye system by high-pressure temperature-jump method.
    Nakatani H; Hiromi K
    J Biochem; 1984 Jul; 96(1):69-72. PubMed ID: 6490608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cyclodextrins in biological fluids by high-performance liquid chromatography with negative colorimetric detection using post-column complexation with phenolphthalein.
    Frijlink HW; Visser J; Drenth BF
    J Chromatogr; 1987 Apr; 415(2):325-33. PubMed ID: 3584371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex formation between alpha-cyclodextrin and 4-substituted phenols studied by potentiometric and competitive spectrophotometric methods.
    Lin SF; Connors KA
    J Pharm Sci; 1983 Nov; 72(11):1333-8. PubMed ID: 6644598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclodextrins on sparingly soluble salts.
    Hirsch W; Fried V; Altman L
    J Pharm Sci; 1985 Oct; 74(10):1123-5. PubMed ID: 4078713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of association constants of beta-cyclodextrin and beta-cyclodextrin-bearing polymers with drugs by high-performance liquid chromatography.
    Sébille B; Thuaud N; Piquion J; Behar N
    J Chromatogr; 1987 Nov; 409():61-9. PubMed ID: 2826514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversed-phase high-performance liquid chromatographic separation of substituted phenolic compounds with a beta-cyclodextrin bonded phase column.
    Chang CA; Wu Q; Armstrong DW
    J Chromatogr; 1986 Feb; 354():454-8. PubMed ID: 3700535
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 16. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
    Han SM; Atkinson WM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
    [No Abstract]   [Full Text] [Related]  

  • 17. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 20. Cycloamylose complexation of adamantane derivatives.
    Gelb RI; Schwartz LM; Laufer DA
    Life Sci; 1983 Jul; 33(1):83-5. PubMed ID: 6865649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.